Regulatory Approval Denied to Market Gardasil for Women Older Than 27

by Savitha C Muppala on  April 8, 2011 at 1:52 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

Merck was unable to get the nod from FDA to market Gardasil to women between the ages of 27 and 45.
 Regulatory Approval Denied to Market Gardasil for Women Older Than 27
Regulatory Approval Denied to Market Gardasil for Women Older Than 27

Federal drug regulators held their ground and denied permission to Merck to use its cervical-cancer vaccine Gardasil in older women, as a protection against HPV or human papillomavirus. HPV can cause cervical cancer and genital warts.

The vaccine had received approval from FDA in 2006 for use in females between ages 9 to 26.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Uterine Cancer 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive